Skip to main content
EMVISION MEDICAL DEVICES LTD logo

EMVISION MEDICAL DEVICES LTD — Investor Relations & Filings

Ticker · EMV ISIN · AU0000028375 ASX Manufacturing
Open in API
Filings indexed 304 across all filing types
Latest filing 2021-12-07 Capital/Financing Update
Country AU Australia
Listing ASX EMV

About EMVISION MEDICAL DEVICES LTD

https://emvision.com.au/

EMVision Medical Devices Ltd is a medical technology company focused on the development and commercialization of portable medical imaging devices. The company specializes in electromagnetic microwave imaging technology designed for the rapid diagnosis and monitoring of stroke and traumatic brain injury. Its primary product is a portable brain scanner intended for use at the point of care, including intensive care units, emergency departments, and ambulances. By utilizing non-ionizing radiation, the technology provides a safe, cost-effective, and mobile alternative to traditional neuroimaging modalities like CT and MRI. The device aims to facilitate earlier clinical intervention by enabling bedside assessment, potentially improving patient outcomes through faster detection of ischemic and hemorrhagic strokes.

Recent filings

Filing Released Lang Actions
EMVision Receives $3.4m Non-Dilutive Funding this Quarter 2 pages 172.9KB
Capital/Financing Update Classification · 95% confidence The document is a company announcement dated 8/12/21 from EMVision Medical Devices Ltd. It details receipt of non-dilutive funding totaling $3.4 million during the quarter, including government grants, partner contributions, and an R&D tax incentive rebate. The content focuses on funding updates and cash reserves, with no financial statements or detailed financial performance data. The document is relatively short (5864 characters) and reads as a quarterly funding update rather than a full financial report. There is no indication of earnings results, management discussion, or regulatory certifications. Therefore, it fits best under Capital/Financing Update (CAP), which covers company fundraising and financing activities.
2021-12-07 English
Application for quotation of securities - EMV 6 pages 27.9KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX (Australian Securities Exchange) for Emvision Medical Devices Ltd. It details the issuance and conversion of options into ordinary fully paid shares, including the number of securities to be quoted, issue dates, and other issuance details. There is no financial performance data, earnings information, or management discussion. The document is clearly an announcement related to capital changes, specifically the issuance and quotation of new shares resulting from option exercises. This fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief announcement of a report or a certification but a substantive announcement of capital changes.
2021-12-01 English
Notification regarding unquoted securities - EMV 7 pages 30.4KB
Share Issue/Capital Change Classification · 100% confidence The document is a detailed notification regarding the issue of unquoted equity securities by Emvision Medical Devices Ltd. It includes specifics about the securities issued, such as options under an employee incentive scheme, issue dates, security descriptions, and compliance with ASX listing rules. The content focuses on the issuance and characteristics of new securities rather than financial results, management changes, or regulatory certifications. This matches the definition of a Share Issue/Capital Change filing, which covers announcements about new share issues or capital changes. The document length (8223 characters) and detailed content confirm it is the announcement itself, not a brief notice or a report publication announcement.
2021-12-01 English
Clinical Trial Data Drives Confidence for Expanded Studies 5 pages 262.1KB
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from EMVision Medical Devices Ltd about clinical trial data related to their medical imaging device for stroke diagnosis. It includes extensive information on the study design, patient data, results, and future plans for expanded clinical studies. The content focuses on clinical trial results and product development progress rather than financial performance or regulatory filings. There is no indication that this is an official financial report, audit report, or regulatory filing. It is also not a presentation, call transcript, or management report. The document is a corporate announcement of clinical trial results, which does not fit into the typical financial or governance filing categories. Given the nature of the content, the best fitting category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous corporate announcements that do not fit other categories.
2021-11-29 English
AGM Chairman's Address & Presentation 9 pages 1.6MB
AGM Information Classification · 100% confidence The document is titled 'AGM CHAIRMAN’S ADDRESS & PRESENTATION' and references the 2021 Annual General Meeting (AGM) of EMVision Medical Devices Limited. It contains the Chairman's address, CEO presentation highlights, company milestones, team information, and strategic updates typically shared during an AGM. There is no detailed financial report or audit data, nor is it a transcript of a call or a regulatory filing. The content is consistent with materials presented at an AGM meeting rather than a formal annual report or other filing types. The document length is substantial and contains the actual presentation content, not just an announcement of a report publication. Therefore, the appropriate classification is AGM Information (AGM-R).
2021-11-24 English
Results of Annual General Meeting 2 pages 175.4KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'RESULTS OF ANNUAL GENERAL MEETING' and details the voting results of resolutions passed at the AGM of EMVision Medical Devices Ltd. It includes specific voting percentages, proxy votes, and mentions compliance with Listing Rule 3.13.2 and section 251AA of the Corporations Act. The content is focused on the official announcement of shareholder voting outcomes rather than the AGM materials or the full annual report. The document length is 2580 characters, which is relatively short and consistent with a voting results announcement rather than a full report. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2021-11-24 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.